<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0409979" disease_type="Disease or Syndrome" abbrv="">Neonatal lupus</z:e> is a model of passively acquired <z:hpo ids='HP_0002960'>autoimmunity</z:hpo> whereby anti-SSA/Ro-SSB/La antibodies target the fetal heart and neonatal skin in a minority of cases </plain></SENT>
<SENT sid="1" pm="."><plain>Since neuro-psychiatric impairment has been reported in humans and mice exposed prenatally to a variety of maternal autoantibodies including anti-Ro/La, this study was initiated to evaluate the potential neurotoxic effects of these specific autoantibodies and the overall frequency of <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo>, general health, and somatic growth of children with <z:e sem="disease" ids="C0409979" disease_type="Disease or Syndrome" abbrv="">neonatal lupus</z:e> and their unaffected siblings </plain></SENT>
<SENT sid="2" pm="."><plain>In addition to the general health questionnaires maintained on family members enrolled in the Research Registry for <z:e sem="disease" ids="C0409979" disease_type="Disease or Syndrome" abbrv="">Neonatal Lupus</z:e> (RRNL), specific questionnaires related to neuro-psychiatric development were sent to <z:hpo ids='HP_0000001'>all</z:hpo> mothers whose children (both affected and unaffected) were older than 5 years of age </plain></SENT>
<SENT sid="3" pm="."><plain>Controls consisted of healthy friends </plain></SENT>
<SENT sid="4" pm="."><plain>Of 121 anti-Ro exposed children meeting the inclusion criteria, information was returned on 104 (33 cardiac manifestations of <z:e sem="disease" ids="C0409979" disease_type="Disease or Syndrome" abbrv="">neonatal lupus</z:e>, 20 rash, and 51 unaffected siblings) and 22 of the friend controls </plain></SENT>
<SENT sid="5" pm="."><plain>The mean age of <z:hpo ids='HP_0000001'>all</z:hpo> of the children was 14.5 years (range 5-39) </plain></SENT>
<SENT sid="6" pm="."><plain>In total, 42 (40%) of the 104 anti-Ro exposed children were reported to have a neuro-<z:e sem="disease" ids="C0004936" disease_type="Mental or Behavioral Dysfunction" abbrv="">psychiatric disorder</z:e>, compared with 6 (27%) of the friend controls (p = 0.34) </plain></SENT>
<SENT sid="7" pm="."><plain>For 8 (24%) of the <z:hpo ids='HP_0001678'>congenital heart block</z:hpo> (CHB) children (6 boys, 2 girls) the mothers reported attention problems </plain></SENT>
<SENT sid="8" pm="."><plain>Four, <z:hpo ids='HP_0000001'>all</z:hpo> boys, were on stimulants </plain></SENT>
<SENT sid="9" pm="."><plain>Of the <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rash</z:e> children, 4 (20%) (2 boys, 2 girls) had attention problems with one boy on <z:chebi fb="1" ids="31836">Ritalin</z:chebi> </plain></SENT>
<SENT sid="10" pm="."><plain>Of the unaffected siblings, 9 (18%) (8 boys and 1 girl) had attention problems with 3 boys on stimulants </plain></SENT>
<SENT sid="11" pm="."><plain>One (5%) of the control children (a girl) had attention problems, not requiring therapy </plain></SENT>
<SENT sid="12" pm="."><plain>There was no statistical difference in attention problems between the groups (p = 0.120) </plain></SENT>
<SENT sid="13" pm="."><plain><z:hpo ids='HP_0000708'>Behavioral problems</z:hpo> were present in <z:hpo ids='HP_0000001'>all</z:hpo> groups with no statistical differences noted </plain></SENT>
<SENT sid="14" pm="."><plain>The prevalence of <z:hpo ids='HP_0000716'>depression</z:hpo>, <z:hpo ids='HP_0000739'>anxiety</z:hpo>, developmental delays, learning, hearing, and speech problems were not significantly different between groups </plain></SENT>
<SENT sid="15" pm="."><plain>In the CHB children, one boy has <z:hpo ids='HP_0000100'>nephrotic syndrome</z:hpo> and one girl has <z:hpo ids='HP_0003765'>psoriasis</z:hpo> </plain></SENT>
<SENT sid="16" pm="."><plain>In the <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rash</z:e> children, one girl has <z:hpo ids='HP_0005681'>juvenile rheumatoid arthritis</z:hpo> </plain></SENT>
<SENT sid="17" pm="."><plain>In the unaffected group there are five children with <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo>, two with <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel diseases</z:e> (one boy and one girl), one boy has a <z:e sem="disease" ids="C0949691" disease_type="Disease or Syndrome" abbrv="SPDA1">spondyloarthropathy</z:e>, one girl has <z:hpo ids='HP_0002229'>alopecia areata</z:hpo> and one young woman has <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="18" pm="."><plain>In the control group one boy has <z:e sem="disease" ids="C0034152" disease_type="Disease or Syndrome" abbrv="">Henoch Schonlein</z:e> <z:hpo ids='HP_0000979'>purpura</z:hpo> </plain></SENT>
<SENT sid="19" pm="."><plain>There were four cases of <z:hpo ids='HP_0000821'>hypothyroidism</z:hpo>, possibly secondary to <z:hpo ids='HP_0000872'>Hashimoto's thyroiditis</z:hpo>, three in boys with CHB and one in a girl with <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rash</z:e> </plain></SENT>
<SENT sid="20" pm="."><plain>None of the unaffected siblings or controls had <z:hpo ids='HP_0000821'>hypothyroidism</z:hpo> </plain></SENT>
<SENT sid="21" pm="."><plain>Parental reporting of neuro-psychiatric abnormalities was high in anti-Ro exposed children regardless of the <z:e sem="disease" ids="C0409979" disease_type="Disease or Syndrome" abbrv="">neonatal lupus</z:e> manifestation </plain></SENT>
<SENT sid="22" pm="."><plain>However, medication use was limited and although the frequency of this reporting was greater than friend controls, it did not reach significance </plain></SENT>
</text></document>